US-based medical device firm CyMedica Orthopedics has commercially introduced its QB1 System, a device developed to treat quadriceps muscle atrophy.
Featuring neuromuscular electrical stimulation (NMES) technology, the QB1 System combines three products including postoperative knee brace, a form-fitting conductive garment and NMES control interface.
The new NMES system is said to provide enhanced intensity electrical muscle stimulation, while maintaining patient comfort.
Its advanced closed-loop system monitors and adjusts the electrical stimulation power provided to the patient to maintain consistent and comfortable quadriceps activation.
CyMedica Orthopedics cofounder Dr Struan Coleman said: "The QB1 will allow the orthopedic surgeon to treat every patient like a professional athlete by initiating neuromuscular activation immediately following knee surgery.
"For the first time, the patient, the surgeon and the physical therapist will all be equally involved in postoperative rehabilitation of the knee."
The company exhibited the new system at the Arthroscopy Association of North American Arthroscopic Society for Sports Medicine (AANA) annual meeting in Los Angeles.